Pediatrix Medical Group, Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 1.91B | 1.97B | 1.99B | 2.01B | 1.91B | -4.9% | |
| Cost of Revenue | (1.40B) | (1.50B) | (1.57B) | (1.56B) | (1.44B) | -7.5% | |
Gross Profit | 513.24M | 467.03M | 421.56M | 454.34M | 471.88M | 3.9% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | (263.36M) | (231.40M) | (227.54M) | (238.44M) | (240.79M) | 1.0% | |
| General & Administrative | (263.36M) | (231.40M) | (227.54M) | (238.44M) | (240.79M) | 1.0% | |
| Depreciation & Amortization | (32.15M) | (35.64M) | (36.17M) | (32.23M) | (21.83M) | -32.3% | |
Operating Income (EBIT) | 202.92M | 172.69M | 7.32M | -68.71M | 231.09M | -436.3% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | 19.05M | — | |
| Interest Expense | (68.72M) | (39.70M) | (42.08M) | (40.74M) | (35.97M) | -11.7% | |
| Other Income/Expenses (Net) | -67.69M | -91.32M | -55.68M | -32.63M | -14.65M | -55.1% | |
Income Before Tax | 135.23M | 81.37M | -48.36M | -101.34M | 216.43M | -313.6% | |
| Income Tax Expense | (27.24M) | (18.81M) | (12.05M) | (2.27M) | (51.04M) | -2346.7% | |
Net Income | 130.96M | 66.33M | -60.41M | -99.07M | 165.39M | -266.9% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $2 | $1 | $-1 | $-1 | $2 | -263.0% | |
| Weighted Avg Shares Outstanding | 86.42M | 82.95M | 84.02M | 83.33M | 85.27M | 2.3% | |
| Weighted Avg Shares Outstanding (Diluted) | 86.42M | 84.12M | 82.20M | 83.33M | 85.27M | 2.3% | |
EBITDA | 236.10M | 156.70M | 29.89M | -28.37M | 274.22M | -1066.5% |
Explore MD
MD in the Healthcare
Small Cap